Catalyst Wire Dossier Catalyst Wire Dossier

ADHD drug candidate (bioequivalence study)

· Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADHD drug candidate (bioequivalence study), covering 2011-10-27 to 2011-10-27. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence (BE) Study in Healthy Subjects [Phase 1]

See pricing